D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
The striatum, which is the major component of the basal ganglia in the brain, is regulated in part by dopaminergic input from the substantia nigra. Severe movement disorders result from the loss of striatal dopamine in patients with Parkinson's disease. Rats with lesions of the nigrostriatal dopamine pathway caused by 6-hydroxydopamine (6-OHDA) serve as a model for Parkinson's disease and show alterations in gene expression in the two major output systems of the striatum to the globus pallidus and substantia nigra. Striatopallidal neurons show a 6-OHDA-induced elevation in their specific expression of messenger RNAs (mRNAs) encoding the D 2 dopamine receptor and enkephalin, which is reversed by subsequent continuous treatment with the D 2 agonist quinpirole. Conversely, striatonigral neurons show a 6-OHDA-induced reduction in their specific expression of mRNAs encoding the D 1 dopamine receptor and substance P, which is reversed by subsequent daily injections of the D 1 agonist SKF-38393. This treatment also increases dynorphin mRNA in striatonigral neurons. Thus, the differential effects of dopamine on striatonigral and striatopallidal neurons are mediated by their specific expression of D 1 and D 2 dopamine receptor subtypes, respectively.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The NAc is composed of a vast array of transcriptionally distinct neuronal subtypes, where medium spiny neurons (MSNs) make up the majority (>95%) of the cells (16).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
In the citing paper
“These neurons are defined by their transcriptional profiles, including dopamine receptor 1 (D1) vs. dopamine receptor 2 (D2) expression, substance P and enkephalin, and other enriched genes (16–18).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Fluoro-gold: a new fluorescent retrograde axonal tracer with numerous unique properties
Schmued, L. C., & Fallon, J. H. (1986) · Brain Research · doi:10.1016/0006-8993(86)91199-6 · Cited by 886
Freund, T. F., Powell, J. F., & Smith, A. D. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90294-x · Cited by 865
Hikosaka, O., & Wurtz, R. H. (1983) · Journal of Neurophysiology · doi:10.1152/jn.1983.49.5.1285 · Cited by 808
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Gerfen, C. R., & Scott Young, W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91217-6 · Cited by 658
Self-citationMultiple D2 dopamine receptors produced by alternative RNA splicing
Monsma, F. J., McVittie, L. D., Gerfen, C. R., Mahan, L. C., & Sibley, D. R. (1989) · Nature · doi:10.1038/342926a0 · Cited by 641
Self-citationProjection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
Kawaguchi, Y., Wilson, C., & Emson, P. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03421.1990 · Cited by 565
Research works printed but not linked: 1
- HONG, J.S., ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY 24: 223 (1980).
Cited by
Items 601–700 of 1,013
Dong, J., Hawes, S., Wu, J., Le, W., & Cai, H. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.645287 · Cited by 103
Beaudry, G., Langlois, M., Weppe, I., Rouillard, C., & Lévesque, D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751694.x · Cited by 103
An inhibitory corticostriatal pathway
Rock, C., Zurita, H., Wilson, C., & Apicella, A. J. (2016) · eLife · doi:10.7554/elife.15890 · Cited by 85
Visanji, N. P., Fox, S. H., Johnston, T. H., Reyes, G., Millan, M. J., & Brotchie, J. M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.010 · Cited by 102
From symphony to cacophony: Pathophysiology of the human basal ganglia in Parkinson disease
Gale, J. T., Amirnovin, R., Williams, Z. M., Flaherty, A. W., & Eskandar, E. N. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.11.005 · Cited by 102
Massart, R., Guilloux, J., Mignon, V., Sokoloff, P., & Díaz, J. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06842.x · Cited by 102
Villalba, R. M., & Smith, Y. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1735-6 · Cited by 102
Liu, Y., Aragona, B. J., Young, K. A., Dietz, D. M., Kabbaj, M., Mazei-Robison, M., Nestler, E. J., & Wang, Z. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911998107 · Cited by 101
“Thus, although DA transmission within the NAcc plays an important role in the response to AMPH and the formation of partner preferences, these behaviors are likely mediated through distinct microcircuitries that comprise striatal projection systems (33, 36).”
BackgroundA Genetically Defined Compartmentalized Striatal Direct Pathway for Negative Reinforcement
Xiao, X., Deng, H., Furlan, A., Yang, T., Zhang, X., Hwang, G.-R., Tucciarone, J., Wu, P., He, M., Palaniswamy, R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.032 · Cited by 101
“We found that the Tshz1eYFP neurons sent projections to the globus pallidus internus (GPi), substantia nigra pars reticulata (SNr), and the globus pallidus externus (GPe) (Figure S1J), which are known targets of dMSNs (Gerfen et al., 1990; Jin et al., 2014).”
BackgroundDrago, J., Padungchaichot, P., Accili, D., & Fuchs, S. (1998) · Developmental Neuroscience · doi:10.1159/000017313 · Cited by 101
Villalba, R. M., & Smith, Y. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.011 · Cited by 101
Dudman, J. T., & Gerfen, C. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-374245-2.00017-6 · Cited by 101
Self-citationRHS2, a POU domain-containing gene, and its expression in developing and adult rat.
Moine, C. L., & Young, W. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3285 · Cited by 101
Huntley, G. W., Morrison, J. H., Prikhozhan, A., & Sealfon, S. C. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90107-m · Cited by 100
Presynaptic μ and δ Opioid Receptor Modulation of GABAAIPSCs in the Rat Globus Pallidus In Vitro
Stanford, I. M., & Cooper, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-04796.1999 · Cited by 100
Seong, H. J., & Carter, A. G. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1367-12.2012 · Cited by 100
Functional connectivity and integrative properties of globus pallidus neurons
Jaeger, D., & Kita, H. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.050 · Cited by 100
Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators
Ribeiro, J. A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00230-7 · Cited by 100
Bal, A., Bachelot, T., Savasta, M., Manier, M., Verna, J. M., Benabid, A. L., & Feuerstein, C. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90227-5 · Cited by 99
Role of Serotonin via 5-HT2B Receptors in the Reinforcing Effects of MDMA in Mice
Doly, S., Bertran‐Gonzalez, J., Callebert, J., Bruneau, A., Banas, S. M., Belmer, A., Boutourlinsky, K., Hervé, D., Launay, J., & Maroteaux, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007952 · Cited by 99
Haber, S. N., Adler, A., & Bergman, H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374236-0.10020-3 · Cited by 99
A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system
Latini, S., Pazzagli, M., Pepeu, G., & Pedata, F. (1996) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(96)00044-4 · Cited by 99
D1 dopamine receptor: A putative neurochemical and behavioral link to cocaine action
Hummel, M., & Unterwald, E. M. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10078 · Cited by 98
Steiner, H., & Gerfen, C. R. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903530204 · Cited by 98
Self-citationSchuster, S., Doudnikoff, É., Ottosson, D. R., Berthet, A., Aubert, I., Ittrich, C., Bloch, B., Cenci, M. A., Surmeier, D. J., Hengerer, B., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.008 · Cited by 98
Molecular basis of dopamine replacement therapy and its side effects in Parkinson’s disease
You, H., Mariani, L., Mangone, G., de Nailly, D. L. F., Charbonnier‐Beaupel, F., & Corvol, J. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2813-2 · Cited by 97
Mechanisms of Action of Drugs of Abuse on the Developing Fetal Brain
Malanga, C. J., & Kosofsky, B. E. (1999) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30070-8 · Cited by 97
Sheng, M., Lu, D., Shen, Z., & Poo, M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901712116 · Cited by 97
Hassani, O.-K., & Féger, J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00765-9 · Cited by 97
The role of dopamine in modulating the structure and function of striatal circuits
Surmeier, D. J., Shen, W., Day, M., Gertler, T., Chan, S., Tian, X., & Plotkin, J. L. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)83008-0 · Cited by 96
Functional role of ambient GABA in refining neuronal circuits early in postnatal development
Cellot, G., & Cherubini, E. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00136 · Cited by 96
Pillot, C., Ortiz, J., Héron, A., Ridray, S., Schwartz, J.-C., & Arrang, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07272.2002 · Cited by 96
Gelman, B. B., Lisinicchia, J. G., Chen, T., Johnson, K. M., Jennings, K., Freeman, D. H., & Soukup, V. M. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9345-4 · Cited by 96
The role of neuroplasticity in dopaminergic therapy for Parkinson disease
Zhuang, X., Mazzoni, P., & Kang, U. J. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.57 · Cited by 96
Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density
LaHoste, G. J., & Marshall, J. F. (1992) · Synapse · doi:10.1002/syn.890120103 · Cited by 96
Heterogeneity in striatal dopamine circuits: Form and function in dynamic reward seeking
Collins, A. L., & Saunders, B. T. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24587 · Cited by 95
The neuropathological features of neuroacanthocytosis
Rinne, J. O., Daniel, S. E., Scaravilli, F., Pires, M., Harding, A. E., & Marsden, C. D. (1994) · Movement Disorders · doi:10.1002/mds.870090303 · Cited by 95
Multimodal mapping of cell types and projections in the central nucleus of the amygdala
Wang, Y., Krabbe, S., Eddison, M., Henry, F. E., Fleishman, G. M., Lemire, A. L., Wang, L., Korff, W. L., Tillberg, P. W., Lüthi, A., et al. (2023) · eLife · doi:10.7554/elife.84262 · Cited by 95
Sciamanna, G., Bonsi, P., Tassone, A., Cuomo, D., Tscherter, A., Viscomi, M. T., Martella, G., Sharma, N., Bernardi, G., Standaert, D. G., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.001 · Cited by 95
Radad, K., Gille, G., & Rausch, W. (2005) · PubMed · Cited by 95
You, Z. ‐., Herrera‐Marschitz, M., Nylander, I., Goiny, M., O'Connor, W. T., Ungerstedt, U., & Terenius, L. Y. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90540-1 · Cited by 95
The role of excitatory amino acids in experimental models of Parkinson's disease
Ossowska, K. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02250917 · Cited by 95
Ballion, B., Mallet, N., Bézard, E., Lanciego, J. L., & Gonon, F. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06192.x · Cited by 94
Aubert, I., Guigoni, C., Li, Q., Doveró, S., Bioulac, B. H., Gross, C. E., Crossman, A. R., Bloch, B., & Bézard, E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.038 · Cited by 94
Bossé, R., & Paolo, T. D. (1996) · Cellular and Molecular Neurobiology · doi:10.1007/bf02088176 · Cited by 94
Svenningsson, P., Fourreau, L., Bloch, B., Fredholm, B. B., Gonon, F., & Moine, C. L. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00403-5 · Cited by 94
Reward Prediction Error Coding in Dorsal Striatal Neurons
Oyama, K., Hernádi, I., Iijima, T., & Tsutsui, K.-I. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1719-10.2010 · Cited by 93
Genetic Mouse Models of Huntington’s Disease: Focus on Electrophysiological Mechanisms
Cepeda, C., Cummings, D. M., André, V. M., Holley, S. M., & Levine, M. S. (2010) · ASN Neuro · doi:10.1042/an20090058 · Cited by 93
Sa�udo-Pe�a, M. C., Force, M., Tsou, K., Miller, A. S., & Walker, J. M. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2<221::aid-syn12>3.0.co;2-4 · Cited by 93
Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease
Ztaou, S., & Amalric, M. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.02.019 · Cited by 93
Receptor alterations in manganese intoxicated monkeys
Eriksson, H., Gillberg, P., Aquilonius, S., Hedström, K., & Heilbronn, E. (1992) · Archives of Toxicology · doi:10.1007/bf01973632 · Cited by 93
Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson’s Disease
Schintu, N., Frau, L., Ibba, M., Garau, A., Carboni, E., & Carta, A. R. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9061-x · Cited by 93
Epigenetic Effects Induced by Methamphetamine and Methamphetamine‐Dependent Oxidative Stress
Limanaqi, F., Gambardella, S., Biagioni, F., Busceti, C. L., & Fornai, F. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4982453 · Cited by 93
Pollack, A. E., & Fink, J. S. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00168-i · Cited by 93
Interpreting the role of the striatum during multiple phases of motor learning
Cataldi, S., Stanley, A. T., Miniaci, M. C., & Sulzer, D. (2021) · FEBS Journal · doi:10.1111/febs.15908 · Cited by 92
Lin, C., Huang, J.-Y., Ching, C., & Chuang, J. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00510.x · Cited by 92
Subcellular connectivity underlies pathway-specific signaling in the nucleus accumbens
MacAskill, A. F., Little, J. P., Cassel, J. M., & Carter, A. G. (2012) · Nature Neuroscience · doi:10.1038/nn.3254 · Cited by 82
Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors
Ledonne, A., & Mercuri, N. B. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00027 · Cited by 92
Cellular distribution of adenosine A2A receptor mrna in the primate striatum
Svenningsson, P., Le Moine, C., Aubert, I., Burbaud, P., Fredholm, B. B., & Bloch, B. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980921)399:2<229::aid-cne6>3.0.co;2-2 · Cited by 85
MAKOFF, A. J., Graham, J., Arranz, M. J., Forsyth, J., Li, T., Aitchison, K. J., Shaikh, S., & Grünewald, R. A. (2000) · Pharmacogenetics · doi:10.1097/00008571-200002000-00006 · Cited by 92
Striatal structure and function in mood disorders: a comprehensive review
Marchand, W. R., & Yurgelun‐Todd, D. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00874.x · Cited by 91
Behavioural pharmacology of glutamate in the basal ganglia
Schmidt, W., Bubser, M., & Hauber, W. (1992) · PubMed · doi:10.18419/opus-6924 · Cited by 91
D1-D2 Dopamine Receptor Synergy Promotes Calcium Signaling via Multiple Mechanisms
Chun, L. S., Free, R. B., Doyle, T. B., Huang, X., Rankin, M. L., & Sibley, D. R. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.085175 · Cited by 91
Self-citationCoordinated Ramping of Dorsal Striatal Pathways preceding Food Approach and Consumption
London, T. D., Licholai, J. A., Szczot, I., Ali, M. A. S., LeBlanc, K. H., Fobbs, W. C., & Kravitz, A. V. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2693-17.2018 · Cited by 91
Goto, A., NAKAHARA, I., Yamaguchi, T., Kamioka, Y., Sumiyama, K., Matsuda, M., Nakanishi, S., & Funabiki, K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507121112 · Cited by 91
Thiele, S. L., Chen, B., Lo, C., Gertler, T. S., Warre, R., Surmeier, D. J., Brotchie, J. M., & Nash, J. E. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.006 · Cited by 91
Sano, H., Yasoshima, Y., Matsushita, N., Kaneko, T., Kohno, K., Pastan, I., & Kobayashi, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09078.2003 · Cited by 87
Past, Present, and Future of the Pathophysiological Model of the Basal Ganglia
Obeso, J. A., & Lanciego, J. L. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00039 · Cited by 91
Egan, M. F., Hurd, Y. L., Ferguson, J. N., Bachus, S. E., Hamid, E. H., & Hyde, T. M. (1996) · Psychopharmacology · doi:10.1007/bf02806012 · Cited by 91
Regulation of Rat Cortex Function by D1 Dopamine Receptors in the Striatum
Steiner, H., & Kitai, S. T. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-14-05449.2000 · Cited by 91
Santini, E., Feyder, M. T., Gangarossa, G., Bateup, H. S., Greengard, P., & Fisone, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.388413 · Cited by 90
Cause of parkinsonian symptoms: Firing rate, firing pattern or dynamic activity changes?
Nambu, A., Tachibana, Y., & Chiken, S. (2014) · Basal Ganglia · doi:10.1016/j.baga.2014.11.001 · Cited by 90
Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self‐administration
Fagergren, P., Smith, H. R., Daunais, J. B., Nader, M. A., Porrino, L. J., & Hurd, Y. L. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02636.x · Cited by 88
Compartmental function and modulation of the striatum
Prager, E. M., & Plotkin, J. L. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24522 · Cited by 90
Neuronal and behavioural abnormalities in striatal function in DARPP‐32‐mutant mice
Hiroi, N., Fienberg, A. A., Haile, C. N., Alburges, M., Hanson, G. R., Greengard, P., & Nestler, E. J. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00570.x · Cited by 81
Dopaminergic neural grafts after fifteen years: results and perspectives
Herman, J., & Abrous, D. N. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90055-8 · Cited by 90
Tallaksen‐Greene, S. J., Wiley, R. G., & Albin, R. L. (1992) · Brain Research · doi:10.1016/0006-8993(92)91044-f · Cited by 90
Temporal Convergence of Dynamic Cell Assemblies in the Striato-Pallidal Network
Adler, A., Katabi, S., Finkes, I., Israel, Z., Prut, Y., & Bergman, H. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4830-11.2012 · Cited by 89
Rodríguez, M., Abdala, P., Barroso‐Chinea, P., Obeso, J. A., & González‐Hernández, T. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00168-1 · Cited by 89
Zhu, X., Ottenheimer, D., & DiLeone, R. J. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00066 · Cited by 78
Wang, J. Q., & McGinty, J. F. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199602)22:2<114::aid-syn4>3.0.co;2-g · Cited by 86
Dopamine and opioid systems interact within the nucleus accumbens to maintain monogamous pair bonds
Resendez, S. L., Keyes, P. C., Day, J. J., Hambro, C., Austin, C. J., Maina, F. K., Eidson, L. N., Porter-Stransky, K. A., Nevárez, N., McLean, J. W., et al. (2016) · eLife · doi:10.7554/elife.15325 · Cited by 88
“…and KORs interact to mediate selective aggression Previous studies have shown that the DA and the dynorphin/KOR systems function in sequence of each other, with stimulation of D1-like receptor promoting downstream activation of the dynorphin/ KOR system (Gerfen et al., 1990; Carlezon et al., 1998).”
Neural Mechanisms Underlying Repetitive Behaviors in Rodent Models of Autism Spectrum Disorders
Gandhi, T., & Lee, C. C. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592710 · Cited by 88
Huntington’s Disease: New Frontiers in Therapeutics
Pan, L., & Feigin, A. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01093-3 · Cited by 88
GABAB and group I metabotropic glutamate receptors in the striatopallidal complex in primates
Smith, Y., Charara, A., Hanson, J. E., Paquet, M., & Levey, A. I. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19640555.x · Cited by 88
Boegman, R. J., & Vincent, S. R. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199601)22:1<70::aid-syn8>3.0.co;2-f · Cited by 88
Action sequencing is impaired in D1A‐deficient mutant mice
Cromwell, H. C., Berridge, K. C., Drago, J., & Levine, M. S. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00250.x · Cited by 81
Kindlundh, A. M. S., Lindblom, J., Bergström, L., Wikberg, J. E. S., & Nyberg, F. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01402.x · Cited by 88
Obeso, J. A., Grandas, F., Herrero, M. T., & HOROWSKI, R. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00584.x · Cited by 88
Chapter 3: Catecholaminergic-cholinergic interaction in the basal forebrain
Záborszky, L., Cullinan, W. E., & Luine, V. N. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62379-1 · Cited by 88
Comparative Review of Dopamine Receptor Agonists in Parkinsonʼs Disease
Uitti, R. J., & Ahlskog, J. E. (1996) · CNS Drugs · doi:10.2165/00023210-199605050-00006 · Cited by 88
Bernard, V., Gardiol, A., Faucheux, B. A., Bloch, B., Agid, Y., & Hirsch, É. C. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960513)368:4<553::aid-cne7>3.0.co;2-3 · Cited by 88
Cenci, M. A., & Björklund, A. (1993) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1993.tb00959.x · Cited by 88
Heterogeneous dopamine receptor changes in early and late Huntington's disease
Richfield, E. K., O'Brien, C. F., Eskin, T., & Shoulson, I. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90448-3 · Cited by 87
Defining the Homo- and Heterodimerization Propensities of Metabotropic Glutamate Receptors
Lee, J., Munguba, H., Gutzeit, V. A., Singh, D. R., Kristt, M., Dittman, J. S., & Levitz, J. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107605 · Cited by 87
Zachry, J. E., Kutlu, M. G., Yoon, H. J., Leonard, M. Z., Chevée, M., Patel, D. D., Gaidici, A., Kondev, V., Thibeault, K. C., Bethi, R., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.11.023 · Cited by 87
Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats
Kuter, K. Z., Śmiałowska, M., Wierońska, J. M., Zieba, B. A., Wardas, J., Pietraszek, M., Nowak, P. G., Biedka, I., Roczniak, W., Konieczny, J., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.018 · Cited by 87
Angulo, J. A. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09368.x · Cited by 87
Egan, M. F., Hurd, Y. L., Hyde, T. M., Weinberger, D. R., Wyatt, R. J., & Kleinman, J. E. (1994) · Synapse · doi:10.1002/syn.890180303 · Cited by 86
Gerfen, C. R. (2004) · The Rat Nervous System · doi:10.1016/b978-012547638-6/50019-5 · Cited by 85
Self-citation
Metadata
- Authors
- Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1990-12-07
- Volume
- 250
- Issue
- 4986
- Pages
- 1429-1432
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1991603311
- Cited by
- 2,967
- References
- 38
- Citations by year
- 2026: 54 · 2025: 60 · 2024: 73 · 2023: 64 · 2022: 89 · 2021: 84 · 2020: 79 · 2019: 85 · 2018: 90 · 2017: 79 · 2016: 102 · 2015: 106 · 2014: 95 · 2013: 79 · 2012: 97
- FWCI
- 27.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- dopamine D1 receptor, dopamine D2 receptor, striatonigral neurons, striatopallidal neurons, gene expression, 6-hydroxydopamine lesion, Parkinson's disease model, substantia nigra, globus pallidus, enkephalin, substance P, dynorphin, quinpirole, SKF 38393, basal ganglia, dopamine agonists
- MeSH terms
- Animals, Cerebral Cortex, Corpus Striatum, Ergolines, Gene Expression Regulation, Globus Pallidus, Hydroxydopamines, Models, Neurological, Neurons, Receptors, Dopamine, RNA, Messenger, Substantia Nigra, Thalamus, Oligonucleotide Probes, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, Oxidopamine, Receptors, Dopamine D1, Receptors, Dopamine D2, Quinpirole, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.